MedTrace Logo

Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)

NCT06633276 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-05-14

No results posted yet for this study

Summary

This pilot study will test the feasibility of using nanopore sequencing for breast cancer diagnosis in Tanzania. It aims to show that nanopore sequencing is non-inferior to the current standard of care, with the potential for faster and more cost-efficient results. By enhancing the speed and accuracy of diagnosis, this approach could improve treatment planning and outcomes for patients in resource-limited settings.

Conditions

  • Breast Cancer Invasive

Sponsors & Collaborators

  • German Cancer Research Center

    collaborator OTHER

  • Kilimanjaro Christian Medical Centre,Moshi,Tanzania

    collaborator UNKNOWN

  • University of Bonn

    lead OTHER

Principal Investigators

  • Oliver Henke, MD · Section Global Health, University Hospital Bonn

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2026-04-30
Completion
2026-05-31

Countries

  • Tanzania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06633276 on ClinicalTrials.gov